Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.
about
Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directionsEpithelial Regeneration After Gastric Ulceration Causes Prolonged Cell-Type AlterationsHistory of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer.Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells.Gastric de novo Muc13 expression and spasmolytic polypeptide-expressing metaplasia during Helicobacter heilmannii infectionMetachronous gastric cancer after successful Helicobacter pylori eradication.Establishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomach.miR-30-HNF4γ and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomachOverexpression of Plasminogen Activator Inhibitor-1 in Advanced Gastric Cancer with Aggressive Lymph Node MetastasisExpression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis.Chronicles of a cancer foretold: 35 years of gastric cancer risk assessmentNotch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis.The Development of Spasmolytic Polypeptide/TFF2-Expressing Metaplasia (SPEM) During Gastric Repair Is Absent in the Aged StomachMurine Models of Gastric Corpus Preneoplasia.Distinct metaplastic and inflammatory phenotypes in autoimmune and adenocarcinoma-associated chronic atrophic gastritisIL-10 Plays a Pivotal Role in Tamoxifen-Induced Spasmolytic Polypeptide-Expressing Metaplasia in Gastric Mucosa.Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.Indoleamine 2,3-dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and is Associated with Type II Hypersensitivity/Autoimmunity.The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival.Serum Level of Trefoil Factor 2 can Predict the Extent of Gastric Spasmolytic Polypeptide-Expressing Metaplasia in the H. pylori-Infected Gastric Cancer Relatives.Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori.A Summary of the 2016 James W. Freston Conference of the American Gastroenterological Association: Intestinal Metaplasia in the Esophagus and Stomach: Origins, Differences, Similarities and Significance.Helicobacter-induced gastric inflammation alters the properties of gastric tissue stem/progenitor cells.Targeted Apoptosis of Parietal Cells Is Insufficient to Induce Metaplasia in Stomach.Maturity and age influence chief cell ability to transdifferentiate into metaplasia.Injury, repair, inflammation and metaplasia in the stomach.Pyloric metaplasia, pseudopyloric metaplasia, ulcer-associated cell lineage and spasmolytic polypeptide-expressing metaplasia: reparative lineages in the gastrointestinal mucosa.A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach.Unique Cellular Lineage Composition of the First Gland of the Mouse Gastric Corpus.
P2860
Q26778023-C5278E70-DC43-492F-8C9A-AA36CC6C28BAQ30816835-797C6EED-9B1A-4B9F-8383-2E06D7F7FFD9Q33594828-61486EA3-26F7-496C-89E6-6F50139FAF8FQ33711746-29E149E4-F268-4592-9001-A97CEAD86AC2Q34059028-DC076D4A-9A5C-4114-AD88-2D9DC1B763C0Q34137273-B7BA5819-B330-4B2D-975F-89C7D4F0EC96Q34356044-936E7EBC-BAEB-44D7-8007-434A578B601AQ34468252-8C42ED76-ECEB-4FEE-950F-8010F7244D56Q36186928-CEFBCC93-DA42-42BC-B60B-1A5804AD26F8Q36730863-D4A640F8-4E5F-46C7-B708-DB74489E0257Q36782625-F61F9FF1-1B90-4B3E-86BD-59F862844FA8Q36859578-873200F8-09D0-4AAE-8013-F69AFD5A5549Q37227163-29C476C2-4953-420E-99C5-B62BEAA4CF46Q37297521-C2957071-270A-40CF-8784-4F3F4FA5A3AEQ37594950-33F37660-63D5-4D11-80D7-F14F53853FD9Q37741814-47947669-EA98-45C0-92D3-188A4625824BQ38401636-C9427B47-F385-4A1D-B8A2-7BFE56E470F6Q39979747-3927D718-3F35-4FF9-84B2-8E106F4BED78Q40045246-98E153A1-D0D9-4A1B-91C0-38AD6612DC9CQ40048875-AA9A61A3-FCE7-45CC-AF28-AD9AC14BD3E5Q40661433-216FD7F2-99F7-4CD8-A115-ABDFF993D47DQ40694864-EDA3AC07-B0C0-480F-AE13-E14CA4728834Q46360679-635F5572-D75C-42F7-8F7B-195C7347A971Q47134611-49F57FD8-4E0F-46D3-9B7E-24E788712BCAQ48017785-7C656CAE-5463-476B-9AEA-EF80F5298FC2Q48028364-84620743-1BD7-4661-8233-21C6F22BCA40Q50087583-F9A1C665-B5FC-4C22-9883-0FF3B9080E82Q50420719-C54E444D-2E32-45EB-8BEC-3118DD70E40FQ50455880-A604C37C-0878-4484-B8A3-86B44341B51CQ50475132-FC2F634A-042D-4FCD-84CF-9BEBDC46EF37
P2860
Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Heterogeneity in mouse spasmol ...... rs of metaplastic progression.
@ast
Heterogeneity in mouse spasmol ...... rs of metaplastic progression.
@en
Heterogeneity in mouse spasmol ...... rs of metaplastic progression.
@nl
type
label
Heterogeneity in mouse spasmol ...... rs of metaplastic progression.
@ast
Heterogeneity in mouse spasmol ...... rs of metaplastic progression.
@en
Heterogeneity in mouse spasmol ...... rs of metaplastic progression.
@nl
prefLabel
Heterogeneity in mouse spasmol ...... rs of metaplastic progression.
@ast
Heterogeneity in mouse spasmol ...... rs of metaplastic progression.
@en
Heterogeneity in mouse spasmol ...... rs of metaplastic progression.
@nl
P2093
P2860
P1433
P1476
Heterogeneity in mouse spasmol ...... rs of metaplastic progression.
@en
P2093
Bonnie J LaFleur
James R Goldenring
Jared A Weis
Josane F Sousa
Ki Taek Nam
Nadia A Ameen
Paul E Finke
Victoria G Weis
P2860
P304
P356
10.1136/GUTJNL-2012-302401
P407
P50
P577
2012-07-07T00:00:00Z